Company Name, Ticker, Customers, else..

Veru Inc (NASDAQ: VERU)

Sector • Healthcare Industry • Major Pharmaceutical Preparations

Industry • Major Pharmaceutical Preparations

Sector • Healthcare

Veru Inc 's

Name: Veru Inc Comparisons to its Competitors and Market Share - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use/

Competitiveness

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

VERU Sales vs. its Competitors Q3 2026

Comparing the current results to its competitors, Veru Inc reported Revenue decrease in the 3 quarter 2026 year on year by 0 %, despite the revenue increase by the most of its competitors of 14.25 %, recorded in the same quarter.

• List of VERU Competitors

Select the Relationship:

Competition ▼

Select the Category:

Comparison ▼

Competition ▼

Basic Report▼

Revenue Growth Comparisons

Net Income Comparison

Veru Inc , slower than the average decrease reported by the company's competitors of -83.84 %. recorded a net loss and most of the company's competitors saw a decline in earnings by -83.84 %

<< VERU Stock Performance Comparisons

<< See the full list of VERU competitors

*Market share is calculated based on total revenue.

News about Veru Inc Contracts

s for appointing Dr. Steven B. Heymsfield as the Principal Investigator for its Phase 2b clinical trial of enobosarm....

July 29, 2024
Veru Inc. Engages Investors at BTIG Virtual Biotechnology Conference and Makes Progress with Enobosarm Clinical Trials for High-Quality Weight Loss Veru Inc. (NASDAQ: VERU), a late clinical-stage biopharmaceutical company headquartered in Miami, Florida, is at the forefront of innovation in the healthcare sector. On July 29, 2024, the company announced its participation in the upcoming BTIG Virtual Biotechnology Conference, scheduled for August 5, 2024. This event will provide an opportunity for Veru to engage in one-on-one meetings with investors, highlighting its commitment to transparency and communication with stakeholders as it continues to develop cutting-edge medicinesFocused on preserving muscle whil...

VERU's Stock Performance relative to its Competitors

Publicly Traded Peers of Veru Inc

Edesa Biotech Inc
Share Performance

-49.56%

This Quarter

Edesa Biotech Inc

Profile

Edesa Biotech Inc's business model focuses on the development and commercialization of innovative therapeutics in the field of dermatology and gastrointestinal diseases.

More about Edesa Biotech Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 36.120 mill.	$ - mill.	$ -14.102 mill.

Allarity Therapeutics Inc
Share Performance

-14.88%

Over The Past 5 Days

Allarity Therapeutics Inc

Profile

Allarity Therapeutics Inc is a biotechnology company that leverages its unique drug response profiling platform to develop personalized cancer treatments. They use AI algorithms to match patients with the most effective therapies by analyzing their individual molecular profiles.

More about Allarity Therapeutics Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 16.388 mill.	$ - mill.	$ -12.334 mill.

Gt Biopharma Inc
Share Performance

+2,275.86%

30 Days

Gt Biopharma Inc

Profile

Gt Biopharma Inc's business model revolves around developing innovative immunotherapies for the treatment of various cancers. The company focuses on harnessing the power of the immune system to target and eliminate cancer cells through its proprietary technology platform. Gt Biopharma Inc aims to advance its therapies through clinical trials and ultimately commercialize them for the benefit of patients worldwide.

More about Gt Biopharma Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 10.699 mill.	$ - mill.	$ -28.611 mill.

Integrated Biopharma Inc
Share Performance

-35.00%

One Year

Integrated Biopharma Inc

Profile

Integrated Biopharma Inc's business model can be described as a vertically integrated health and wellness company focused on producing and distributing nutritional and dietary supplements.

More about Integrated Biopharma Inc's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 5.653 mill.	$ 42.568 mill.	$ -2.842 mill.

Aptevo Therapeutics Inc
Share Performance

-93.00%

One Year

Aptevo Therapeutics Inc

Profile

Aptevo Therapeutics Inc operates as a biotechnology company that focuses on the development of novel oncology and hematology therapeutics. The company primarily generates revenue through the sale of its products and potential collaborations with other pharmaceutical companies.

More about Aptevo Therapeutics Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 2.261 mill.	$ - mill.	$ -26.505 mill.

46 more competitors available

Sources: Veru Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Saturday, September 26, 2026 7:39 AM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Veru Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.